Intersect Capital’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$279K Sell
1,663
-3,105
-65% -$667K 0.08% 250
2022
Q1
$1.2M Sell
4,768
-266
-5% -$66.8K 0.23% 89
2021
Q4
$1.29M Sell
5,034
-155
-3% -$37.9K 0.24% 83
2021
Q3
$1.26M Buy
5,189
+479
+10% +$117K 0.22% 91
2021
Q2
$974K Buy
4,710
+915
+24% +$186K 0.17% 102
2021
Q1
$715K Buy
3,795
+795
+27% +$140K 0.14% 118
2020
Q4
$493K Buy
+3,000
New +$439K 0.11% 138
2020
Q1
Sell
-1,519
Closed -$225K 175
2019
Q4
$225K Buy
+1,519
New +$204K 0.08% 149
2019
Q3
Sell
-1,500
Closed -$203K 172
2019
Q2
$203K Buy
+1,500
New +$190K 0.08% 163

Other funds holding HCA

Intersect Capital's HCA Position: Q2 2022 in Review

Intersect Capital reduced its HCA Healthcare (HCA) stake by 65% in Q2 2022, selling an estimated $667K and leaving 1,663 shares worth $279K. The position accounts for 0.08% of the portfolio, ranked #250.

Intersect Capital first reported a position in HCA in Q2 2019 and has held it in 9 quarters since. The position peaked at $1.29M in Q4 2021. 884 funds tracked by Wall St. Rank hold HCA as of Q2 2022.

  • Intersect Capital held 1,663 shares of HCA Healthcare worth $279K as of Q2 2022.
  • Intersect Capital sold 3,105 HCA Healthcare shares in Q2 2022, an estimated $667K.
  • HCA Healthcare made up 0.08% of Intersect Capital's portfolio in Q2 2022, its #250 holding.
  • Intersect Capital first reported a position in HCA Healthcare in Q2 2019 and has held it in 9 quarters since.
  • Intersect Capital's HCA Healthcare position peaked at $1.29M in Q4 2021.
  • 884 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2022.

Based on Intersect Capital's 13F filing for Q2 2022, filed 2 Sep 2022.